-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SRiHmakCBI2HFvrjwlhR60LoGYJCkA6G5ELgtg/JvWXjvYkqRivxVVYg6tZBUDra 9L/hSFbLrBKt+7Hbn9l6OQ== 0000912057-02-032019.txt : 20020814 0000912057-02-032019.hdr.sgml : 20020814 20020814145425 ACCESSION NUMBER: 0000912057-02-032019 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20020814 ITEM INFORMATION: Financial statements and exhibits ITEM INFORMATION: FILED AS OF DATE: 20020814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSITE DIAGNOSTICS INC CENTRAL INDEX KEY: 0000834306 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 330288606 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-21873 FILM NUMBER: 02735153 BUSINESS ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6194554808 MAIL ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 8-K 1 a2086759z8-k.htm FORM 8-K
QuickLinks -- Click here to rapidly navigate through this document

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report: August 14, 2002
(Date of earliest event reported)


BIOSITE INCORPORATED
(Exact name of registrant as specified in its charter)

Delaware   000-21873   33-0288606
(State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)

11030 Roselle Street, San Diego, California 92121
(Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code:    (858) 455-4808





ITEM 7    Financial Statements and Exhibits.

    (C)
    Exhibits.

    Exhibit 99.1   Statement Under Oath of Principal Executive Officer Regarding Facts and Circumstances Relating to Exchange Act Filings

 

 

Exhibit 99.2

 

Statement Under Oath of Principal Financial Officer Regarding Facts and Circumstances Relating to Exchange Act Filings


ITEM 9    REGULATION FD DISCLOSURE.

        This information is not filed pursuant to the Securities Exchange Act and is not incorporated by reference into any Securities Act registration statements.

        On August 14, 2002, for purposes of Order No. 4-460 and Section 21(a)(1) of the Securities Exchanges Act of 1934, statements were voluntarily filed with the Securities and Exchange Commission by the Principal Executive Officer and the Principal Financial Officer of Biosite Incorporated which are attached as Exhibits 99.1 and 99.2 to this report.

2



SIGNATURE

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

        Dated: August 14, 2002

    BIOSITE INCORPORATED

 

 

By

/s/  
CHRISTOPHER J. TWOMEY      
Christopher J. Twomey
Vice President, Finance and
Chief Financial Officer

3



INDEX TO EXHIBITS

Exhibit
Number

  Exhibit
Exhibit 99.1   Statement Under Oath of Principal Executive Officer Regarding Facts and Circumstances Relating to Exchange Act Filings

Exhibit 99.2

 

Statement Under Oath of Principal Financial Officer Regarding Facts and Circumstances Relating to Exchange Act Filings

4




QuickLinks

SIGNATURE
INDEX TO EXHIBITS
EX-99.1 3 a2086759zex-99_1.htm EXHIBIT 99.1
QuickLinks -- Click here to rapidly navigate through this document


Exhibit 99.1


Statement Under Oath of Principal Executive Officer and Principal Financial Officer
Regarding Facts and Circumstances Relating to Exchange Act Filings

I, Kim D. Blickenstaff, state and attest that:

        (1)  To the best of my knowledge, based upon a review of the covered reports of Biosite Incorporated, and, except as corrected or supplemented in a subsequent covered report:

      no covered report contained an untrue statement of a material fact as of the end of the period covered by such report (or in the case of a report on Form 8-K or definitive proxy materials, as of the date on which it was filed); and

      no covered report omitted to state a material fact necessary to make the statements in the covered report, in light of the circumstances under which they were made, not misleading as of the end of the period covered by such report (or in the case of a report on Form 8-K or definitive proxy materials, as of the date on which it was filed).

        (2)  I have reviewed the contents of this statement with the Company's audit committee.

        (3)  In this statement under oath, each of the following, if filed on or before the date of this statement, is a "covered report":

      Annual Report on Form 10-K for the fiscal year ended December 31, 2001 of Biosite Incorporated;

      all reports on Form 10-Q, all reports on Form 8-K and all definitive proxy materials of Biosite Incorporated filed with the Commission subsequent to the filing of the Form 10-K identified above; and

      any amendments to the foregoing.

/s/  KIM D. BLICKENSTAFF      
Kim D. Blickenstaff
August 14, 2002
  Subscribed and shown to before me
this 14th day of August 2002.

 

 

/s/  
KRISTIE REED      
Notary Public
My Commission Expires: June 28, 2006
 
    
   



QuickLinks

Statement Under Oath of Principal Executive Officer and Principal Financial Officer Regarding Facts and Circumstances Relating to Exchange Act Filings
EX-99.2 4 a2086759zex-99_2.htm EXHIBIT 99.2
QuickLinks -- Click here to rapidly navigate through this document


Exhibit 99.2


Statement Under Oath of Principal Executive Officer and Principal Financial Officer
Regarding Facts and Circumstances Relating to Exchange Act Filings

I, Christopher J. Twomey, state and attest that:

        (1)  To the best of my knowledge, based upon a review of the covered reports of Biosite Incorporated, and, except as corrected or supplemented in a subsequent covered report:

      no covered report contained an untrue statement of a material fact as of the end of the period covered by such report (or in the case of a report on Form 8-K or definitive proxy materials, as of the date on which it was filed); and

      no covered report omitted to state a material fact necessary to make the statements in the covered report, in light of the circumstances under which they were made, not misleading as of the end of the period covered by such report (or in the case of a report on Form 8-K or definitive proxy materials, as of the date on which it was filed).

        (2)  I have reviewed the contents of this statement with the Company's audit committee.

        (3)  In this statement under oath, each of the following, if filed on or before the date of this statement, is a "covered report":

      Annual Report on Form 10-K for the fiscal year ended December 31, 2001 of Biosite Incorporated;

      all reports on Form 10-Q, all reports on Form 8-K and all definitive proxy materials of Biosite Incorporated filed with the Commission subsequent to the filing of the Form 10-K identified above; and

      any amendments to the foregoing.

/s/  CHRISTOPHER J. TWOMEY      
Christopher J. Twomey
August 14, 2002
  Subscribed and shown to before me
this 14th day of August 2002.

 

 

/s/  
KRISTIE REED      
Notary Public
My Commission Expires: June 28, 2006
 
    
   



QuickLinks

Statement Under Oath of Principal Executive Officer and Principal Financial Officer Regarding Facts and Circumstances Relating to Exchange Act Filings
-----END PRIVACY-ENHANCED MESSAGE-----